WIA
DMAC icon

World Investment Advisors’s DiaMedica Therapeutics DMAC Stock Holding History

World Investment Advisors’s Portfolio DMAC Stock Details DMAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$250K Hold
36,975
– – ﹤0.01% 1331
2026
Q1 		$250K Hold
36,975
– – ﹤0.01% 1362
2025
Q4 		$294K Buy
36,975
+2,650
+8% +$19.8K ﹤0.01% 1196
2025
Q3 		$236K Buy
34,325
+2,350
+7% +$12.7K ﹤0.01% 1094
2025
Q2 		$125K Buy
31,975
+6,325
+25% +$24.7K ﹤0.01% 1107
2025
Q1 		$97.2K Buy
25,650
+3,735
+17% +$21.4K ﹤0.01% 1036
2024
Q4 		$119K Buy
+21,915
New +$103K ﹤0.01% 987

Other funds holding DMAC

CLG
Cooperman Leon G $3.55B AUM 41.85% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BL
Bleichroeder LP New York $559M AUM 83.7% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

World Investment Advisors's DMAC Position: Q2 2026 in Review

World Investment Advisors held its DiaMedica Therapeutics (DMAC) position steady in Q2 2026 at 36,975 shares worth $250K. The position accounts for ﹤0.01% of the portfolio, ranked #1331.

World Investment Advisors first reported a position in DMAC in Q4 2024 and has held it in 7 quarters since. The position peaked at $294K in Q4 2025. 89 funds tracked by Wall St. Rank hold DMAC as of Q2 2026.

  • World Investment Advisors held 36,975 shares of DiaMedica Therapeutics worth $250K as of Q2 2026.
  • World Investment Advisors left its DiaMedica Therapeutics share count unchanged in Q2 2026.
  • DiaMedica Therapeutics made up ﹤0.01% of World Investment Advisors's portfolio in Q2 2026, its #1331 holding.
  • World Investment Advisors first reported a position in DiaMedica Therapeutics in Q4 2024 and has held it in 7 quarters since.
  • World Investment Advisors's DiaMedica Therapeutics position peaked at $294K in Q4 2025.
  • 89 funds tracked by Wall St. Rank held DiaMedica Therapeutics as of Q2 2026.

Based on World Investment Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.